Back to search

Article

A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG

2026-04-18

Abstract excerpt

PIGA-CDG is a congenital disorder of glycosylation caused by pathogenic partial loss-of-function variants in the PIGA gene. PIGA encodes an enzyme responsible for the catalytic transfer of N-acetylglucosamine to phosphatidylinositol during the first step of glycosylphosphatidylinositol anchor biosynthesis. Loss of this enzyme has a widespread phenotypic impact, but primarily results in neurological symptoms includ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
13b27c10-81f7-5822-9db6-4164a9665a9b
DOI
10.64898/2026.04.17.719256
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDGDOI 10.64898/2026.04.17.719256
Select a neighboring publication to make it the new centre.